Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

1997-05-02

Original market date: See footnote 1

1997-04-07

Product name:

CLOPIXOL-ACUPHASE 50MG/ML

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02230405

Product Monograph/Veterinary Labelling:

Date: 2014-04-08 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

LUNDBECK CANADA INC
2600 Alfred-Nobel, Suite 400
St-Laurent
Quebec
Canada  H4S 0A9

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

28:16.08.32   THIOXANTHENES

Anatomical Therapeutic Chemical (ATC): See footnote 4

N05AF05  ZUCLOPENTHIXOL

Active ingredient group (AIG) number:See footnote 5

0127601001

List of active ingredient(s)
Active ingredient(s) Strength
ZUCLOPENTHIXOL ACETATE 50 MG / ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: